Clinical Trials
2 trialsNCT07394374 2026-02-06
A Phase 1/2 Study of CG001419 Tablets in Adult Subjects With Locally Advanced or Metastatic Solid Tumours Harbouring NTRK Gene Abnormalities
Cullgen (Shanghai),Inc
Phase 1/2 Recruiting
NCT02122913 2026-02-05
A Study to Test the Safety of the Investigational Drug Larotrectinib in Adults That May Treat Cancer
Bayer
Phase 1 Completed